C-reactive protein (CRP), a biomarker of systemic inflammation, independently associates with endothelial dysfunction, subclinical atherosclerosis and arteriosclerosis[1], [2] and clinical manifestations of atherosclerosis in the general population[3], [4]. The gene discussed is CRP; the disease is arteriosclerosis.